Bravident Extends Holiday Sale as Demand Surges for Its Walk Adventure Kit Deals to Help Dog Owners Finally Say Goodbye to Chaotic Walks

NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — With nearly 68 million dog-owning households in the U.S., everyday walks often come with real frustrations–tangled leashes, too many items to juggle, and dogs that suddenly pull ahead. To address these common pain points, Bravident is officially extending its seasonal Holiday Sale. The all-in-one setup brings together […]

LM Funding America Announces November 2025 Production and Operational Update

(NASDAQ:LMFA), – Bitcoin treasury as of November 30, 2025 valued at $27.5 million or $2.25 per share1 TAMPA, Fla., Dec. 04, 2025 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today announced its preliminary, unaudited Bitcoin mining and operational update for the month

Darktrace Releases New Innovations in Darktrace / EMAIL(TM) to Stop Emerging Cross-Domain Attacks and Protect Outbound Trust

Cambridge, UK, Dec. 04, 2025 (GLOBE NEWSWIRE) — New research finds approximately 17% of email threats bypass Secure Email Gateways but are stopped by Darktrace's AI[1] New enhancements strengthen protection against threats that move across channels, like email bombing campaigns, as the volume of these attacks surges 100x New brand verification capabilities introduced as phishing

Firefly Aerospace Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – FLY

(NasdaqGM:FLY), LOS ANGELES, Dec. 04, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Firefly Aerospace Inc. (“Firefly” or “the Company”) (NASDAQ: FLY) for violations of the federal securities laws. Shareholders who purchased shares of FLY during the class period listed are encouraged to contact the firm regarding

Ajax Therapeutics Presents Preclinical Data on Differentiated Efficacy Profile of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the American Society of Hematology Annual Meeting

– Data demonstrate superior efficacy compared to ruxolitinib, an approved type I JAK2 inhibitor, including reductions in mutant allele burden and bone marrow fibrosis, key markers of disease modification – – AJ1-11095 is currently in a Phase 1 clinical trial in patients with myelofibrosis, previously treated with a type I JAK2 inhibitor – NEW YORK

Greif Named to America’s Most Responsible Companies 2026 List for Seventh Consecutive Year

(NYSE:GEF),(NYSE:GEF.B),(NYSE:GEF-B), DELAWARE, Ohio, Dec. 04, 2025 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a global leader in performance packaging products and services, today announced that it has been named to Newsweek's America's Most Responsible Companies 2026 list – for a seventh consecutive year. Greif has been included on the list every year since its

BTT Medical Institute Announces Unprecedented Case of Total Reversal of ALS through Re-engineering of the Nobel Prize-Winning Fever Therapy into a Brain-Guided, Artificial Intelligence-Controlled ThermoFebrile Treatment

MIAMI, Dec. 04, 2025 (GLOBE NEWSWIRE) — BTT Medical Institute, in collaboration with btt Corp. (Brain Tunnelgenix Technologies Corp.), a medical technology company pioneering brain thermodynamics solutions, today announced the first documented case of total reversal of amyotrophic lateral sclerosis (ALS), a disease long considered irreversible and uniformly fatal, now successfully treated using groundbreaking, noninvasive

Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development

(NASDAQ:ENLV), Nes-Ziona, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, “Enlivex” or “the Company”), today announced that it will host a virtual fireside chat on Thursday, December 11, 2025 at 11:00 am ET. Shai Novik, Executive Chairman of Enlivex, will provide an update on the Company's plans following its recently closed

Siebert Financial and Kakao Pay Securities Expand Strategic Collaboration to deliver Daily U.S. Market Insights to 8 Million Korean Investors

(NASDAQ:SIEB), NEW YORK and SEOUL, South Korea, Dec. 04, 2025 (GLOBE NEWSWIRE) — Siebert Financial Corp. (NASDAQ: SIEB) announced today that Chief Investment Officer Mark Malek is now providing daily U.S. market commentary to approximately 8 million Kakao Pay Securities account holders through the platform's “Very Useful Investment News” channel. Since late November, Kakao Pay

Discuss Closes 2025 With Major AI Innovations Following Its Merger Announcement with Voxco

Seattle, WA, Dec. 04, 2025 (GLOBE NEWSWIRE) — Discuss, the leading AI-powered market insights platform, today announced capabilities that fundamentally change how fast organizations can move from questions to answers. The Q4 release launches Virtual Personas in beta, expands Interview Agent use cases and customization, and introduces integrated Data Visualization within Insights Agent, giving research

Scroll to Top